Newsletter - CADRE Diabetes

Archived Newsletters

5/10/2010 Volume 8:3 - Spring 2010 - Inflammation Inlammation in Diabetes and Pre-diabetes – Vivian Fonseca, MD Islet Inflammation in Type 2 Diabetes - Marc Y Donath, MD C-reactive Protein (CRP) as a Predictor of Cardiovascular Disease Risk - Special Report Obesity: A Chronic Inflammatory Condition - Richard E Pratley, MD Potential Treatments for Underlying Inflammation in Type 2 Diabetes - Dawn Smiley, MD and Guillermo E Umpierrez, MD

9/15/2009 Volume 8:2 - Summer 2009 - Pre-diabetes Harnessing Local Data and Systems to Improve Diabetes Care and Surveillance – Ali H Mokdad, PhD Management of Hypertension and Dyslipidemia in Pre-diabetes - John M Flack, MD, MPH and Samar Nasser, PAC, MPH Is Fructose in Beverages a Problem in Diabetes and Obesity? - George A Bray, MD Can Lifestyle Intervention Trump Genetic Risk for Type 2 Diabetes? - Linda M Delahanty, MS, RD

6/15/2009 Volume 8:1 - Spring 2009 - Women and Diabetes Polycystic Ovary Syndrome: An Opportunity for Prevention of Diabetes – John E Nestler, MD From the Pedersen Hypothesis to HAPO, Normoglycemia is Still the Objective for Diabetes in Pregnancy – Alison Semrad, DO and Lois Jovanovič, MD, FACE, FACP, FACN Diabetes and Menopause – JoAnn Manson, MD, DrPH Thiazolidinediones and Skeletal Health in Postmenopausal Women – Andrew Grey, MD

11/15/2008 Volume 7:3 - Autumn 2008 - Conference Reporter Issue Taking Medications: Understanding the Barriers and Seeking Solutions - Melinda D Maryniuk, MEd, RD, FADA, CDE Inhibition of SGLT2: A Novel Way to Lower Plasma Glucose and Treat Diabetes - Derek LeRoith, MD, PhD, FACP and Vivian Fonseca, MD HEART2D - Matthew C Riddle, MD Incretin-Based Therapies - Julio Rosenstock, MD

6/1/2008 Volume 7:2 - Summer 2008 - New Technologies Candidates for New Diabetes Technologies: Implications for Clinical Trials and Practice - Tim Wysocki, PhD Current Issues in Insulin Pump Therapy - Bruce Bode, MD; Linda Fredrickson, MA, RN, CDE; and William Tamborlane, MD, FAAP, FACE Current Developments in Glucose Sensors/Monitoring - Howard Wolpert, MD

3/1/2008 Volume 7:1 - Winter 2008 - Obesity and Type 2 Diabetes Introduction - Melissa M. Miles, Executive Director A Public Health Perspective on Obesity - Deborah A. Galuska, MPH, PhD and Ann L. Albright, PhD, RD Management of Obesity in Type 2 Diabetes - Osama Hamdy, MD, PhD Current Developments in Type 2 Diabetes and Bariatric Surgery - David Flum, MD, MPH Conference Reporter: The Alliance for Continuing Medical Education - 33rd Annual Meeting

12/1/2007 Volume 6:3 - Autumn 2007 - Conference Reporter Issue Introduction - Steven E. Kahn, MB, ChB The Rosiglitazone Controversy - John E. Gerich, MD New Directions in Lifestyle Management in Type 2 Diabetes - Melinda D. Maryniuk, MEd, RD, FADA, CDE The New ACE/AACE Road Map for the Prevention and Treatment of Type 2 Diabetes - Paul S. Jellinger, MD, MACE

7/15/2007 Volume 6:2 - Summer 2007 - Long-Term Clinical Trials Long-Term Clinical Trials: Worth Their Wait - Steven E. Kahn, MB, ChB After Metformin Monotherapy, What Next? - Irl B. Hirsch, MD and Silvio E. Inzucchi, MD The Quest for a Durable Type 2 Diabetes Treatment - John E. Gerich, MD

3/30/2007 Volume 6:1 - Winter 2007 - Novel Therapies New Approaches to Diabetes Management: Inhaled Insulin - William T. Cefalu, MD Benefits of Early Combination Therapy in Type 2 Diabetes - John E. Gerich, MD GLP-1: Where Are We Today? - Jens Juul Holst, MD

11/30/2006 Volume 5:3 - Autumn 2006 - Conference Reporter Issue Conference Reporter Issue (ADA and EASD) ◦ Results from the Dream Trial – Vivian Fonseca, MD ◦ Exenatide: What’s New with this Glucagon-Like Peptide-1 Analogue – John E Gerich, MD ◦ Dipeptidyl Peptidase-4 Inhibition as an Approach in Type 2 Diabetes Treatment – William T Cefalu, MD ◦ Late-Breaking Clinical Trials: Hyperglycemia and Mortality in Critically Ill Patients & Effect of Hyperglycemia on Cognitive Function – Vivian Fonseca, MD ◦ Is the A1C Test Changing? Current Research and Its Implications – Matthew C Riddle, MD

6/1/2006 Volume 5:2 - Summer 2006 - Diabetes & Pregnancy The Importance of Preconception Care in Women With Preexisting Diabetes - Lois Jovanovic, MD, FACE, FACP, FACN Urgent Early Intervention in a Pregnant Patient with Preexisting Diabetes - Lois Jovanovic, MD, FACE, FACP, FACN Strategies to Prevent Diabetes Recurrence in Women with Prior Gestational Diabetes - Thomas A Buchanan, MD Medical Nutrition Therapy in Pregnancy Complicated by Diabetes - Davida F Kruger, MSN, APRN, BC-ADM & Melinda D Maryniuk, MEd, RD, FADA, CDE

1/1/2006 Volume 5:1 - Winter 2006 - Conference Reporter Issue The Metabolic Syndrome Debate: It is Time to Get Our Act Together - Steven E Kahn, MB, ChB Conference Reporter (ADA & EASD) ◦ RIO-Diabetes: Phase III Outcomes – John E Gerich, MD ◦ EDIC: Early Aggressive Glycemic Control Decreases Cardiovascular Events – Desmond A Schatz, MD ◦ Exenatide Provides Glucose Control Equivalent to Insulin Glargine – Davida F Kruger, MSN, APRN, BC-ADM ◦ The Results of PROactive – Steven E Kahn, MB, ChB ◦ Obesity Treatment is Cost-Effective but Underreimbursed – Melinda D Maryniuk, MEd, RD, FADA, CDE

10/1/2005 Volume 4:3 - Autumn 2005 - Adolescents & Diabetes Caring for Children and Adolescents With Type 1 Diabetes - Francine R Kaufman, MD Treatment Plans for Adolescent Type 2 Diabetes - Desmond A Schatz, MD; John E Gerich, MD; William V Tamborlane, MD Prediabetes and the Metabolic Syndrome in Obese Children - Sonia Caprio, MD

10/1/2005 Special Issue - Autumn 2005 Proceedings from a joint symposium conducted by CADRE and the American Association of Diabetes Educators on “Reducing Cardiovascular Risk in the Patient With Type 2 Diabetes: Strategies to Implement Medical Nutrition Therapy and Overcome Barriers to Insulin Use”

7/1/2005 Volume 4:2 - Summer 2005 - Nontraditional Risk Factors Nontraditional Risk Factors and Type 2 Diabetes - Vivian Fonseca, MD Strategies to Prevent Progression in a High-Risk Patient - John E Gerich, MD; Henry N Ginsberg, MD; Richard W Nesto, MD Thinking Beyond Simple Obesity: Intra-abdominal Fat is an Important Nontraditional Risk Factor - Steven E Kahn, MB, ChB

1/1/2005 Volume 4:1 - Winter 2005 - Incretin Mimetics; Prioritizing Treatment Incretin Mimetics in the Treatment of Type 2 Diabetes – Daniel J Drucker, MD Prioritizing Treatment for Multiple, Chronic Conditions – Kevin A Peterson, MD, MPH, FRCS(Ed), FAAFP Conference Reporter (ADA) ◦ The Polypill Proposal ◦ Harnessing the Incretin Effect to Treat Type 2 Diabetes

10/1/2004 Volume 3:3 - Autumn 2004 - Cholesterol Management Considerations in the Clinical Application of New Cholesterol Management Guidelines – Vivian Fonseca, MD Lipid Control Following Myocardial Infarction – Paul S Jellinger, MD, MACE Controversies in Care: New LDL Targets—-Too Low Too Soon? – Steven Haffner, MD Ask the Experts – William V Tamborlane, MD & Melinda D Maryniuk, MEd, RD, FADA, CDE

7/1/2004 Volume 3:2 - Summer 2004 - Hypertension Hypertension in Diabetes and Metabolic Syndrome: The “Elusive” Risk Factor! – William T Cefalu, MD Hypertension and Impaired Glucose Tolerance – John Gerich, MD and Ervin Szoke, MD Treating Hypertension in Patients with Diabetes: Implementing Standards of Care in the Clinical Environment

1/1/2004 Volume 3:1 - Winter 2004 - Aggressive Treatment; Neuropathy; Conference Reporter The Case for Aggressive Treatment Before and After Diagnosis in Type 2 Diabetes – Steven E Kahn, MB, ChB Advanced Neuropathy in Type 2 Diabetes – Davida F Kruger, MSN, APRN, BC-ADM & William T Cefalu, MD Conference Reporter (ADA & IDF) ◦ Baseline Characteristics of ADOPT Participants ◦ Inhaled Insulin Safety Results Promising ◦ Lessons from the UKPDS Post-Study Monitoring Program and the Steno-2 Study

10/1/2003 Volume 2:3 - Autumn 2003 - Diabetes in Childhood Treating to Target in Youths With Type 1 Diabetes: New Strategies, New Barriers - William V Tamborlane, MD & Karen Rubin, MD Controversies in Care: Insulin Pump Use in Children - Stuart Weinzimer, MD & Lori Laffel, MD, MPH Distinguishing Between Type 1, Type 2, and Other Forms of Diabetes in Childhood and Adolescence - Desmond Schatz, MD & William Winter, MD

5/1/2003 Volume 2:2 - Spring 2003 - Early Treatment and Diabetes Prevention Lowering the Threshold for Treating Plasma Glucose Levels - John E Gerich, MD Ask the Experts - William T Cefalu, MD; Martha M Funnell, RN, MS, CDE; Melinda D Maryniuk, MEd, RD, FADA, CDE Strategies for Diabetes Prevention: Identifying Pre-diabetes and Implementing a Risk Reduction Education Program - Melinda D Maryniuk, MEd, RD, FADA, CDE

1/1/2003 Volume 2:1 - Winter 2003 - Systems of Care; Conference Reporter Improving Diabetes Outcomes Using Systems of Care - Lawrence Blonde, MD, FACP Updating Clinic Systems to Improve Patient Care - Kevin Peterson, MD, MPH, FRCS (Ed), FAAP Conference Reporter (EASD) ◦ Cardiovascular Dysfunction Precedes Diabetes Diagnosis in Children

10/1/2002 Volume 1:2 - Autumn 2002 - Diabetic Pathophysiology Dual Components of Diabetic Pathophysiology - Steven E Kahn, MB, ChB Ask the Experts - Paul S Jellinger, MD, FACE; David Nathan, MD; Matthew C Riddle, MD Aggressive Treatment of Diabetes - John Buse, MD, PhD, CDE Conference Reporter (ADA) ◦ Glucose-Dependent Insulin Secretagogues, Emerging GLP-1 Compounds

6/1/2002 Volume 1:1 - Summer 2002 - Introduction to CADRE; CADRE's A1C Position Statement Introduction to CADRE - William T Cefalu, MD & Derek LeRoith, MD, PhD, FACP Reducing Complications of Gestational Diabetes - Lois Jovanovic, MD The Diabetes Prevention Program: Addressing the Root Causes of Type 2 Diabetes - Steven E Kahn, MB, ChB CADRE’s A1C Position Statement

CADRE Newsletters

Other Newsletters

Archived Newsletters

forgot password?